Targeting Endothelin A and Angiotensin type 1 receptors with Ambrisentan and Losartan ameliorates cisplatin-induced injury in human tubuloids
- PMID: 41042255
- DOI: 10.1093/ndt/gfaf209
Targeting Endothelin A and Angiotensin type 1 receptors with Ambrisentan and Losartan ameliorates cisplatin-induced injury in human tubuloids
LinkOut - more resources
Full Text Sources
